Akari Therapeutics (AKTX) Enterprise Value (QoQ) (2014 - 2026)
Akari Therapeutics (AKTX) Enterprise Value (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Akari Therapeutics | 86.55 Mn | 86.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.27% |
| Dec 31, 2025 | -3,137.43% |
| Sep 30, 2025 | 94.13% |
| Jun 30, 2025 | -4.88% |
| Mar 31, 2025 | 0.64% |
| Dec 31, 2024 | -18.39% |
| Sep 30, 2024 | 46.23% |
| Jun 30, 2024 | -218.85% |
| Mar 31, 2024 | 65.93% |
| Dec 31, 2020 | -14.11% |
| Sep 30, 2020 | 3.36% |
| Jun 30, 2020 | -62.95% |
| Mar 31, 2020 | -36.47% |
| Dec 31, 2019 | 8.57% |
| Sep 30, 2019 | -129.06% |
| Jun 30, 2019 | 55.47% |
| Mar 31, 2019 | -2.98% |
| Jun 30, 2016 | 9.19% |
| Mar 31, 2016 | 10.87% |
| Dec 31, 2015 | 12.51% |